Amneal Pharmaceuticals Inc - Ordinary Shares - Class A
NYSE:AMRX 3:59:56 PM EDT
| Market Cap (Intraday) | 749.34M |
| Current PE | 42.27 |
| Forward PE | 5.7 |
| 2yr Forward PE | 5.52 |
| 10-Day MA | $5.06 |
| 50-Day MA | $5.00 |
| 200-Day MA | $5.32 |
Amneal Pharmaceuticals Inc - Ordinary Shares - Class A Stock, NYSE:AMRX
400 Crossing Boulevard, 3rd floor, Bridgewater, New Jersey 08807
United States of America
Phone: +1.908.947.3120
Number of Employees: 6000
Description
Amneal Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generics and Specialty segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ.